Adma Biologics (ADMA) Other Working Capital Changes (2011 - 2025)
Adma Biologics (ADMA) reported Other Working Capital Changes of $547000.0 for Q4 2025, up 136.08% on a YoY basis from $231699.4 in Q4 2024, and up 148.97% quarter-over-quarter from -$1.1 million in Q3 2025.
Adma Biologics (ADMA) Other Working Capital Changes (2011 - 2025) Analysis & Trends
Adma Biologics has reported Other Working Capital Changes for 13 years, with the latest figure at $547000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 136.08% year-over-year to $547000.0; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (down 43.41% YoY), and the FY2025 full-year result was $1.5 million, down 43.41% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at $547000.0, up from -$1.1 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $4.0 million in Q3 2024, with the low at -$1.6 million in Q1 2024.
- Historically, Other Working Capital Changes has averaged $325400.0 across 5 years, with a median of -$64095.0 in 2021.
- Annual changes were most pronounced in 2021 — Other Working Capital Changes soared 56704.25% — and 2024, when it slumped 767.84%.
- Adma Biologics' Other Working Capital Changes stood at -$1.5 million in 2021, then soared by 81.76% to -$277238.0 in 2022, then soared by 181.88% to $227000.0 in 2023, then tumbled by 767.84% to -$1.5 million in 2024, then jumped by 136.08% to $547000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $547000.0 (Q4 2025), -$1.1 million (Q3 2025), and -$501000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 547,000.00 |
| Dec 31, 2025 | 547,000.00 |
| Sep 30, 2025 | -1.12 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -501,000.00 |
| Mar 31, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | -1.59 Mn |
| Mar 31, 2024 | -1.59 Mn |
| Dec 31, 2023 | 227,000.00 |
| Dec 31, 2023 | 227,000.00 |
| Sep 30, 2023 | -112,000.00 |
| Sep 30, 2023 | -112,000.00 |